Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:7
  • preuzimanja u poslednjih 30 dana:1
članak: 6 od 616  
Back povratak na rezultate
Vojnosanitetski pregled
2019, vol. 76, br. 1, str. 55-60
jezik rada: engleski
vrsta rada: izvorni naučni članak
doi:10.2298/VSP170312081N

Creative Commons License 4.0
Hipogonadizam u hroničnoj opstruktivnoj bolesti pluća (HOBP) - faktori rizika
aUniversity of Kragujevac, Faculty of Medical Sciences, Department of Internal Medicine, Kragujevac + Clinical Center of Kragujevac, Clinic for Pulmonology, Kragujevac
bClinical Center of Kragujevac, Clinic for Pulmonology, Kragujevac

e-adresa: ljiljanan1@hotmail.com

Sažetak

Uvod/Cilj. Hronična opstruktivna bolest pluća (HOBP) je vodeći uzrok morbiditeta i mortaliteta u plućnoj patologiji. Osim plućnih manifestacija, HOBP karakterišu brojni sistemski efekti, među kojima je opisan i hipogonadizam posebno u grupi muškaraca sa ovom bolešću. Cilj studije bio je procena faktora rizika za pojavu hipogonadizama kod muškaraca sa HOBP. Metode. Istraživanjem je obuhvaćeno 96 bolesnika muškog pola sa HOBP u stabilnoj fazi bolesti. Kod svih bolesnika određena je koncentracija: slobodnog testosterona u serumu, markera sistemske inflamacije, faktora nekroze tumora- alfa (TNF-α), interleukin 1-beta (IL-1β) i C-reaktivnog proteina (CRP), izvršeno je ispitivanje plućne funkcije, parametara gasne razmene, 6-minutni test hoda (6MWT), stanje uhranjenosti i stanje skeletnih mišića (midthigh muscle cross-sectional area - MTCSA), pomoću kompjuterizovane tomografije). Rezultati. Zastupljenost ispitanika sa hipogonadizmom je bila 37.5%. Ispitanici sa hipogonadizmom (slobodan testosteron < 4,5 pg/mL) su imali značajno povećanu koncentraciju TNF-α u serumu (5,88 ± 3,21 vs. 3,16 ± 2,53 pg/mL; p < 0,05), značajno manji MTSCA (68,2 ± 18,72 vs. 91,1 ± 21,4 cm2; p < 0,05) i 6MWT (268,33 ± 32,35 vs. 334,25 ± 43,25 m; p < 0,05). Nije ustanovljena statistički značajna razlika između ove dve grupe ispitanika u pogledu starosti, parametara plućne funkcije i gasne razmene, kao i indeksa telesne mase. Pomoću multivarijantne resgresione analize kao nezavisni prediktor koncentracije slobodnog testosterona izdvojila se serumska vrednost TNF-α (B= -0.157; 95% interval poverenja: - 0.262-0.053). Zaključak. Analizom je ustanovljeno da TNF-α, kao sistemski marker inflamacije, predstavlja nezavisni prediktor za postojanje hipogonadizma kod bolesnika sa HOBP. Hipogonadizam je značajno povezan sa gubitkom mišićne mase i lošijim tolerisanjem napora kod ovih bolesnika.

Ključne reči

Reference

Balasubramanian, V., Naing, S. (2012) Hypogonadism in chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine, 18(2): 112-117
Barker, B., McKenna, S., Mistry, V., Pancholi, M., Patel, H., Haldar, K., Barer, M.R., Steiner, M.C., Brightling, C.E., Bafadhel, M., Pavord, I. (2014) Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, : 975
Choudhury, G., Rabinovich, R., MacNee, W. (2014) Comorbidities and Systemic Effects of Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine, 35(1): 101-130
Čekerevac, I., Lazić, Z., Novković, L., Petrović, M., Ćupurdija, V., Kitanović, G., Todorović, Z., Gajović, O. (2010) Exercise tolerance and dyspnea in patients with chronic obstructive pulmonary disease. Vojnosanitetski pregled, vol. 67, br. 1, str. 36-41
Daabis, R.G., Abdel, R.R.N., Hassan, M.M., Khalil, G.I. (2016) Hypogonadism in patients with chronic obstructive pulmonary disease: relationship with airflow limitation, muscle weakness and systemic inflammation. Alexandria Journal of Medicine, 52(1): 27-33
Debigare, R., Marquis, K., Cote, C.H., Tremblay, R.R., Michaud, A., LeBlanc, P., Maltais, F. (2003) Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest, 124(1): 83-9
Ferrari, R., Caram, L., Faganello, M., Sanchez, F., Tanni, S., Godoy, I. (2015) Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. International Journal of Chronic Obstructive Pulmonary Disease, : 1553
Isidori, A.M., Lenzi, A. (2005) Risk factors for androgen decline in older males: lifestyle, chronic diseases and drugs. J Endocrinol Invest, 28(3 Suppl): 14-22
Kaparianos, A., Argyropoulou, E., Efremidis, G., Spiropoulos, K. (2011) Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study. Eur Rev Med Pharmacol Sci, 15(10): 1149-57
Karadag, F., Ozcan, H., Karul, A. B., Yilmaz, M., Cildag, O. (2009) Sex hormone alterations and systemic inflammation in chronic obstructive pulmonary disease. International Journal of Clinical Practice, 63(2): 275-281
Laghi, F. (2005) Low Testosterone in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 172(9): 1069-1070
Laghi, F., Antonescu-Turcu, A., Collins, E., Segal, J., Tobin, D.E., Jubran, A., Tobin, M.J. (2005) Hypogonadism in Men with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 171(7): 728-733
Laghi, F., Langbein, W. E., Antonescu-Turcu, A., Jubran, A., Bammert, C., Tobin, M.J. (2005) Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 171(6): 598-605
Shaker, A., El-Shora, A., El-Gammal, M., Labib, H.A. (2012) Endocrinal disturbances and systemic inflammatiom in chronic obstructive pulmonary disease (COPD). Egyptian Journal of Chest Diseases and Tuberculosis, 61(3): 81-88
Shrikrishna, D., Patel, M., Tanner, R.J., Seymour, J.M., Connolly, B.A., Puthucheary, Z.A., Walsh, S.L.F., Bloch, S.A., Sidhu, P.S., Hart, N., Kemp, P.R., Moxham, J., Polkey, M.I., Hopkinson, N. (2012) Quadriceps wasting and physical inactivity in patients with COPD. European Respiratory Journal, 40(5): 1115-1122
Snyder, P.J. (2004) Hypogonadism in Elderly Men - What to Do Until the Evidence Comes. New England Journal of Medicine, 350(5): 440-442
van Vliet, M., Spruit, M.A., Verleden, G., Kasran, A., van Herck, E., Pitta, F., Bouillon, R., Decramer, M. (2005) Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 172(9): 1105-1111
Vertkin, A.L., Morgunov, L.Iu., Shakhmanaev, Kh.A. (2013) Hypogonadism and chronic obstructive pulmonary disease. Urologiia, (5): 116-8, 120-2. (Russian)
Zohal, M.A., Hashemipour, S., Karamali, N., Farzam, S.A., Sami, R. (2015) Association of hypogonadism with the severity of chronic obstructive pulmonary disease. JQUMS, 19(4): 19-24